Abstract
Renal transplantation is the treatment of choice for end stage kidney disease. It gives better quality of life and patient survival than hemodialysis. Renal transplant ladies regain fertility within six months after renal transplantation. Pregnancy is allowed in the most of guidelines after one years of rejection free renal transplant period. Immunosuppressive drugs are crucially used even during pregnancy so, we try to minimize the risk of teratogenicity by using azathioprine, Calcineurin inhibitor and steroid. Hereby we report a case of pregnant transplant lady, received sirolimus and Mycophenolate Mofetil during unplanted pregnancy. We discuss her outcome in spite of the risk of teratogenicity. We represent an image of 4D ultrasound showing the fetus beside the transplanted kidney
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Clinical Images and Medical Case Reports
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
